BRCA1 and ovarian carcinoma: The prevalence of PVs in BRCA1 or BRCA2 more than doubled within the subset of tested women with a history of ovarian cancer, with a combined prevalence of 6.1% (3.5% for BRCA1, 2.6% for BRCA2).